학술논문

Unexpected similarities between C9ORF72 and sporadic forms of ALS/FTD suggest a common disease mechanism.
Document Type
article
Source
Subject
New York Genome Center ALS Consortium
Brain
Humans
Amyotrophic Lateral Sclerosis
Polypyrimidine Tract-Binding Protein
Heterogeneous-Nuclear Ribonucleoproteins
DNA-Binding Proteins
Mutagenesis
Insertional
RNA Splicing
Frontotemporal Dementia
C9orf72 Protein
RNA binding proteins
amyotrophic lateral aclerosis
biochemistry
chemical biology
frontotemporal dementia
human
human biology
mRNA splicing
medicine
Acquired Cognitive Impairment
Frontotemporal Dementia (FTD)
ALS
Rare Diseases
Genetics
Alzheimer's Disease Related Dementias (ADRD)
Neurosciences
Dementia
Neurodegenerative
Alzheimer's Disease including Alzheimer's Disease Related Dementias (AD/ADRD)
Brain Disorders
2.1 Biological and endogenous factors
Neurological
Biochemistry and Cell Biology
Language
Abstract
Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) represent two ends of a disease spectrum with shared clinical, genetic and pathological features. These include near ubiquitous pathological inclusions of the RNA-binding protein (RBP) TDP-43, and often the presence of a GGGGCC expansion in the C9ORF72 (C9) gene. Previously, we reported that the sequestration of hnRNP H altered the splicing of target transcripts in C9ALS patients (Conlon et al., 2016). Here, we show that this signature also occurs in half of 50 postmortem sporadic, non-C9 ALS/FTD brains. Furthermore, and equally surprisingly, these 'like-C9' brains also contained correspondingly high amounts of insoluble TDP-43, as well as several other disease-related RBPs, and this correlates with widespread global splicing defects. Finally, we show that the like-C9 sporadic patients, like actual C9ALS patients, were much more likely to have developed FTD. We propose that these unexpected links between C9 and sporadic ALS/FTD define a common mechanism in this disease spectrum.